Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > This is what I was waiting to hear

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Feb 15, 2023 12:42pm

157 Views

Post# 35287721

RE:RE:RE:RE:RE:This is what I was waiting to hear

I still hope Dr Kulkarni will speak to an updated dataset when he presents tomorrow at GU-ASCO, If so, there is still tomorrow AM to issue NR with this data before the meeting, Fingers crossed!

I have trouble comprehending why he might limit his presentation to the older data, especially if newest data would somewhat mitigate/dilute the effects of the initial undertreated patients.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments